| Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection S Havervall, U Marking, J Svensson, N Greilert-Norin, P Bacchus, ... New England Journal of Medicine 387 (14), 1333-1336, 2022 | 133 | 2022 |
| Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study L Wallentin, N Eriksson, M Olszowka, TB Grammer, E Hagström, C Held, ... PLoS medicine 18 (1), e1003513, 2021 | 86 | 2021 |
| Tissue factor non-coagulant signaling–molecular mechanisms and biological consequences with a focus on cell migration and apoptosis M Åberg, A Siegbahn Journal of Thrombosis and Haemostasis 11 (5), 817-825, 2013 | 64 | 2013 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 58 | 2022 |
| Simvastatin induces apoptosis in human breast cancer cells in a NFκB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa M Åberg, M Wickström, A Siegbahn Thrombosis research 122 (2), 191-202, 2008 | 48 | 2008 |
| Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 S Havervall, U Marking, N Greilert-Norin, H Ng, M Gordon, ... EBioMedicine 70, 2021 | 45 | 2021 |
| IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets S Stojkovic, Å Thulin, L Hell, B Thaler, S Rauscher, J Baumgartner, ... Thrombosis and Haemostasis 117 (07), 1379-1390, 2017 | 44 | 2017 |
| Tissue Factor/FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1) M Åberg, M Johnell, M Wickström, A Siegbahn Thrombosis research 127 (2), 141-148, 2011 | 41 | 2011 |
| A quantitative real-time PCR method for tissue factor mRNA A Mälarstig, T Tenno, S Jossan, M Åberg, A Siegbahn Thrombosis research 112 (3), 175-183, 2003 | 41 | 2003 |
| Tissue factor noncoagulant signaling: mechanisms and implications for cell migration and apoptosis M Åberg, O Eriksson, A Siegbahn Seminars in thrombosis and hemostasis, 691-699, 2015 | 36 | 2015 |
| Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection K Blom, U Marking, S Havervall, NG Norin, M Gordon, M García, ... The Lancet Infectious Diseases 22 (7), 943-945, 2022 | 34 | 2022 |
| 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection U Marking, O Bladh, S Havervall, J Svensson, N Greilert-Norin, K Aguilera, ... The Lancet Infectious Diseases 23 (2), 150-152, 2023 | 33 | 2023 |
| Role of extracellular vesicles in pulmonary arterial hypertension: modulation of pulmonary endothelial function and angiogenesis A Khandagale, M Åberg, G Wikström, S Bergström Lind, G Shevchenko, ... Arteriosclerosis, thrombosis, and vascular biology 40 (9), 2293-2309, 2020 | 27 | 2020 |
| Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply. M Åberg, A Smed-Sörensen, C Thålin N Engl J Med, e55-e55, 2022 | 24 | 2022 |
| Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time S Havervall, U Marking, N Greilert‐Norin, M Gordon, H Ng, W Christ, ... Clinical & Translational Immunology 11 (4), e1388, 2022 | 24 | 2022 |
| Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients A Gradin, H Andersson, T Luther, SB Anderberg, S Rubertsson, M Lipcsey, ... Cytokine 146, 155589, 2021 | 19 | 2021 |
| Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation A Siegbahn, J Lindbäck, Z Hijazi, M Åberg, JH Alexander, JW Eikelboom, ... Journal of Thrombosis and Haemostasis 19 (11), 2726-2737, 2021 | 17 | 2021 |
| Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor M Åberg, O Eriksson, D Mokhtari, A Siegbahn Thrombosis and haemostasis 111 (04), 748-760, 2014 | 15 | 2014 |
| Next generation plasma proteomics identifies high-precision biomarker candidates for ovarian cancer U Gyllensten, J Hedlund-Lindberg, J Svensson, J Manninen, T Öst, ... Cancers 14 (7), 1757, 2022 | 13 | 2022 |
| Duration of SARS-CoV-2 immune responses up to six months following homologous or heterologous primary immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines U Marking, S Havervall, N Greilert-Norin, H Ng, K Blom, P Nilsson, ... Vaccines 10 (3), 359, 2022 | 13 | 2022 |
